girentuximab
heidelberg pharmaceutical,esteve,prometheus
['rcc,(-irccs),(-srcc),(-urcc)', 'renal,(-adrenal)', 'zircon', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'girentuximab', 'light chain', 'imab ']
#zircon results from phase 3 study of 89zr-dfo-girentuximab for pet/ct imaging of clear cell #renalcellcarcinoma. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology